Navigation Links
Frozen Yet Potent Viruses Found

Virus causing flu can survive for decades and longer, in frozen lakes and are very well capable of infecting humans and animals once again.//

Dr Scott Rogers of Bowling Green State University of Ohio and his team have found viral RNA perfectly preserved and still potent in a frozen lake of Siberia. Such frozen viruses can be picked up by migratory birds and are capable of causing outbreaks of viral diseases. Those viruses could even cause new epidemics that could sicken and kill many generations after they were last seen, so report researchers in the Journal of Virology.

Migrating birds are said to be the carriers of avian influenza (bird flu) that has spread into 50 countries and killed around 153 persons.

The virus, which causes avian influenza, H5N1 is a descendant of H1N1 that caused a pandemic in 1918, leaving around 40 to 100 million persons dead. This virus was recovered from the frozen body of a victim in Alaska. Were that strain of H1N1 to circulate today, it could cause another serious pandemic because no one alive now has immunity to it, Rogers said.

Dr. Rogers and his team had also discovered a strain of H1 virus that circulated during the late 1930s and 1960s.

The data taken from the study of Dr. Rogers and his team suggested that influenza A virus deposited as the birds begin their autumn migration could be preserved in lake ice and released as the ice melted. This in turn could be picked up again by migrating birds and spread along their paths of flight.
SRM
'"/>




Page: 1

Related medicine news :

1. Frozen Canadian baby stages miraculous recovery
2. Frozen food invite food poisoning
3. Baby Born Through Frozen Donor Egg
4. Frozen fish is costly and also lacks vital nutrients
5. Frozen embryos stored in Britain
6. Salmonella Poisoned Frozen Pasta Hit Six
7. Brain-Damaged Girl Frozen in Time to Remain Child-Sized Forever
8. Not to Be Frozen
9. Californian Baby Creates History - Born from a Frozen Egg and Sperm
10. Potential New Cancer Gene Identified
11. Lack of Smell And Its Potential Risks
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Frozen Yet Potent Viruses Found

(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...scinating areas of biology today, with new experim...about the potential applications of stem cells. Sc...rat // sperm cells to behave like embryonic stem c... to various cell lineages such as a nerve cell, bl...
...ence Livermore National Laboratory are studying th...derstand the mechanism of protein folding. The new...// how a protein is incorrectly folded which leads...ublished in the Journal Proceedings of the Nationa...
...'ll see that lots of middle-aged men are losing th...a bit, it turns out, reports AP. A British compan...und with hundreds more hairs than they had before,...n called hair cloning. An American outfit hopes to...
...the AIDS epidemic, South Africa's first Phase II H...p the International AIDS Vaccine Initiative (IAVI)... The trials will test the safety of "tgAAC09" is a... is based on HIV subtype C, the subtype of the vir...
Other Medicine News:Health News:Sperm stem cells could be an alternative to embryonic stem cells in future 2Health News:Scientists Seek New Ways To Grow Hair On Bald Pates 2Health News:Scientists Seek New Ways To Grow Hair On Bald Pates 3Health News:Scientists Seek New Ways To Grow Hair On Bald Pates 4Health News:Phase II trails of new HIV vaccine to be held in South Africa 2
(Date:9/3/2008)...G, Md., Sept. 3 /- Panacea Pharmaceut...atent Number 7,413,737 covering,antibodies against...AH), a,proprietary human cancer biomarker and ther... collaboration with the Massachusetts Institute of...wide rights to this patent,for development of huma...
(Date:9/3/2008)... Trial Reconfirms Strong Evidence Pycnogenol(R) Lo...ffect on Joints Following Cessation .... 3 /- According to the Center for,Di...on type of arthritis,is on the rise. A new study ...search, reveals Pycnogenol(R), bark extract from t...
(Date:9/2/2008)...ember 3 /-, - This Analysi...e Risk,of Stroke by 34% in Patients With Atrial Fi...eated by Antithrombotic Therapy, The results of a...dy,were presented today at the clinical trial upda...ongress 2008, in Munich, Germany. Previous results...
(Date:9/2/2008)...y Meets Primary Bone Mineral Density and Secondary... Company to Host Conference Call and Webcast Wedn...0 am ET / 5:30 am PT, SAN DIEGO, Sept. 2 /PRNewsw...sdaq: NBIX ) today announced positive safety and ...trial using its proprietary, orally-active,nonpept...
Breaking Medicine Technology:Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 2Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 3Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 4Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 5Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis 6Reflecting on the social implications of human genetics research past present and future 2780 1Reflecting on the social implications of human genetics research past present and future 2780 2Analysis Highlights Economic Contribution of Hospitals to Communities 16090 1Analysis Highlights Economic Contribution of Hospitals to Communities 16090 2Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call 16088 1Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call 16088 2VA Announces SGLI and VGLI Premium Reductions 16086 1VA Announces SGLI and VGLI Premium Reductions 16086 2
...nistration show potential for,new option to improv...07 /PRNewswire-FirstCall/ -- Millennium,Pharmaceut...sitive,data for VELCADE, the market-leading therap... received at least one prior therapy.,These data i...ous,(SC) administration of VELCADE, a new option u...
...llicular Lymphoma Reported,Today at ASCO Annual Me... GlaxoSmithKline plc,announced today long-term eff...eek course of frontline treatment with the BEXXAR(...31 Tositumomab) in,76 patients with newly diagnose.... This regimen was found to induce durable clinica...
Other Medicine Technology:New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 2New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 3New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 4New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 5New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 6New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 78-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7
...xpensive of the series. It has the ability to phot... of the cornea. The model comes with a 9 high-reso... of a patients corneal endothelium, you simply ask...rest. The left side of the chin rest allows you to...
The simplest, most accurate Ortho-K lens fitting system ever!
...ogy (oprifocon A) Contact Lenses are rigid gas per...process that temporarily corrects nearsightedness ... and removes them in the morning. During the day, ...y reduced., ,The Euclid Systems Orthokeratology (o...
...ontact lenses used for corneal refractive therapy,...ss (myopia). The patient wears the lenses overnigh...uring the day, nearsightedness is corrected or gre...ct lenses apply slight pressure to the center of t...
Medicine Products: